Introduction:
Keytruda Injection, containing Pembrolizumab (100mg) as its active ingredient, is a prescription medicine manufactured by MSD Pharmaceuticals Pvt Ltd. It belongs to the class of Monoclonal antibodies (mAb) and falls under the category of ANTI NEOPLASTICS. Keytruda works as a Programmed Cell Death 1 (PD-1) Checkpoint Inhibitor. This medicine is primarily used in the treatment of various types of cancers such as Melanoma, Non-small cell lung cancer, Head and neck cancer, and Cervical cancer. It is administered through injection and should not be self-administered.
Uses:
Keytruda is primarily used in the treatment of the following conditions:
1. Melanoma
2. Non-small cell lung cancer
3. Head and neck cancer
4. Cervical cancer
Price:
The Maximum Retail Price (MRP) for Keytruda Injection (4 ml in 1 vial) is ₹236500.
Dosage:
The dosage of Keytruda Injection is determined by the healthcare provider based on the patient’s condition and medical history. It is usually administered by a doctor or nurse and should not be self-administered.
Benefits:
Keytruda Injection has shown efficacy in the treatment of various types of cancers, including Melanoma, Non-small cell lung cancer, Head and neck cancer, and Cervical cancer. It works by inhibiting the Programmed Cell Death 1 (PD-1) checkpoint, thereby helping the immune system fight cancer cells.
Side Effects:
Some common side effects of Keytruda Injection may include:
1. Rash
2. Fatigue
3. Fever
4. Musculoskeletal (bone, muscle, or joint) pain
5. Stomach pain
6. Nausea
7. Itching
8. Constipation
9. Indigestion
10. Diarrhea
11. Decreased appetite
12. Cough
Active Ingredients:
The active ingredient in Keytruda Injection is Pembrolizumab (100mg), which is a monoclonal antibody (mAb) with anti-neoplastic properties.
Pharmacological Properties:
Keytruda works by inhibiting the Programmed Cell Death 1 (PD-1) checkpoint, thereby enhancing the body’s immune response against cancer cells. It is a targeted therapy that helps the immune system recognize and attack cancer cells more effectively.
Indications:
Keytruda is indicated for the treatment of various cancers, including Melanoma, Non-small cell lung cancer, Head and neck cancer, and Cervical cancer. It is used when other treatment options have not been successful or are not suitable for the patient.
Contraindications:
Keytruda Injection is contraindicated in individuals with a known hypersensitivity to Pembrolizumab or any component of the formulation. It is important to inform your healthcare provider about any allergies before starting treatment with Keytruda.
Drug Interactions:
Keytruda may interact with other medications, so it is essential to inform your healthcare provider about all the medicines, supplements, and herbal products you are currently taking. Certain drugs may affect the efficacy and safety of Keytruda, so proper monitoring is necessary.
Patient Counseling:
Patients receiving Keytruda Injection should be counseled on the following points:
1. Do not self-administer the injection.
2. Inform your healthcare provider about any side effects experienced.
3. Follow the prescribed dosage and schedule.
4. Attend regular follow-up appointments for monitoring.
Clinical Evidence:
Clinical studies and trials have shown the efficacy of Keytruda Injection in the treatment of Melanoma, Non-small cell lung cancer, Head and neck cancer, and Cervical cancer. The results have demonstrated improved outcomes in terms of tumor response rates and overall survival in patients receiving Keytruda.
Frequently Asked Questions:
1. Is Keytruda a chemotherapy drug?
Keytruda is not a traditional chemotherapy drug. It is a targeted therapy known as a checkpoint inhibitor that works by boosting the body’s immune response against cancer cells.
2. How is Keytruda administered?
Keytruda is administered through injection by a healthcare provider. It should not be self-administered.
3. What are the common side effects of Keytruda?
Common side effects of Keytruda may include rash, fatigue, fever, musculoskeletal pain, stomach pain, nausea, itching, constipation, indigestion, diarrhea, decreased appetite, and cough.
4. Can Keytruda be used in other types of cancer?
Keytruda is approved for the treatment of Melanoma, Non-small cell lung cancer, Head and neck cancer, and Cervical cancer. Its use in other types of cancer should be discussed with a healthcare provider.
5. How often do I need to receive Keytruda injections?
The frequency of Keytruda injections and the duration of treatment are determined by the healthcare provider based on the individual’s condition and response to the medication. Regular follow-up appointments are essential for monitoring.
Adding HTML tags to organize the content and FAQ section will enhance the readability and user experience on your website.
MRP:
₹236500
Manufacturer:
MSD Pharmaceuticals Pvt Ltd
Salt:
Pembrolizumab (100mg),
How to UseKeytruda Injection:
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Side Effects of Keytruda Injection:
Rash,Fatigue,Fever,Musculoskeletal (bone, muscle or joint) pain,Stomach pain,Nausea,Itching,Constipation,Indigestion,Diarrhea,Decreased appetite,Cough,
Alternate Medicines for Keytruda Injection:
Prescription Required Status:
Prescription Required
Type of Selection:
4 ml in 1 vial
Chemical Class:
Monoclonal antibody (mAb)
Habit Forming:
No
Therapeutic Class:
ANTI NEOPLASTICS
Action Class:
Programmed Cell Death 1 (PD-1) Checkpoint Inhibitors
. Please note, this information is for educational purposes only and not intended as medical advice.
